These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26670162)

  • 1. The cost-effectiveness of screening for gestational diabetes mellitus in primary and secondary care in the Republic of Ireland.
    Danyliv A; Gillespie P; O'Neill C; Tierney M; O'Dea A; McGuire BE; Glynn LG; Dunne FP
    Diabetologia; 2016 Mar; 59(3):436-44. PubMed ID: 26670162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening uptake rates and the clinical and cost effectiveness of screening for gestational diabetes mellitus in primary versus secondary care: study protocol for a randomised controlled trial.
    O'Dea A; Infanti JJ; Gillespie P; Tummon O; Fanous S; Glynn LG; McGuire BE; Newell J; Dunne FP
    Trials; 2014 Jan; 15():27. PubMed ID: 24438478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring Structural Uncertainty in Cost-Effectiveness Modeling of Gestational Diabetes Screening: An Application Example from Norway.
    Henkel PS; Burger EA; Sletner L; Pedersen K
    Med Decis Making; 2024 May; 44(4):380-392. PubMed ID: 38591188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility, acceptability and uptake rates of gestational diabetes mellitus screening in primary care vs secondary care: findings from a randomised controlled mixed methods trial.
    Tierney M; O'Dea A; Danyliv A; Glynn LG; McGuire BE; Carmody LA; Newell J; Dunne FP
    Diabetologia; 2015 Nov; 58(11):2486-93. PubMed ID: 26242644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes mellitus.
    Lohse N; Marseille E; Kahn JG
    Int J Gynaecol Obstet; 2011 Nov; 115 Suppl 1():S20-5. PubMed ID: 22099435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost of universal screening for gestational diabetes mellitus in Ireland.
    Gillespie P; O'Neill C; Avalos G; O'Reilly M; Dunne F;
    Diabet Med; 2011 Aug; 28(8):912-8. PubMed ID: 21418093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel.
    Marseille E; Lohse N; Jiwani A; Hod M; Seshiah V; Yajnik CS; Arora GP; Balaji V; Henriksen O; Lieberman N; Chen R; Damm P; Metzger BE; Kahn JG
    J Matern Fetal Neonatal Med; 2013 May; 26(8):802-10. PubMed ID: 23311860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New estimates of the costs of universal screening for gestational diabetes mellitus in Ireland.
    Gillespie P; O'Neill C; Avalos G; Dunne FP;
    Ir Med J; 2012 May; 105(5 Suppl):15-8. PubMed ID: 22838102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review on costs and cost-effectiveness of screening and prevention of type 2 diabetes in women with prior gestational diabetes: Exploring uncharted territory.
    Werbrouck A; Schmidt M; Putman K; Benhalima K; Verhaeghe N; Annemans L; Simoens S
    Diabetes Res Clin Pract; 2019 Jan; 147():138-148. PubMed ID: 30529576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic Evaluations of Gestational Diabetes Mellitus Screening: A Systematic Review.
    Mo X; Gai Tobe R; Takahashi Y; Arata N; Liabsuetrakul T; Nakayama T; Mori R
    J Epidemiol; 2021 Mar; 31(3):220-230. PubMed ID: 32448822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of costs and benefits of management of gestational diabetes mellitus.
    Kitzmiller JL; Elixhauser A; Carr S; Major CA; de Veciana M; Dang-Kilduff L; Weschler JM
    Diabetes Care; 1998 Aug; 21 Suppl 2():B123-30. PubMed ID: 9704239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental Cost-Effectiveness Analysis of Gestational Diabetes Mellitus Screening Strategies in Singapore.
    Chen PY; Finkelstein EA; Ng MJ; Yap F; Yeo GS; Rajadurai VS; Chong YS; Gluckman PD; Saw SM; Kwek KY; Tan KH
    Asia Pac J Public Health; 2016 Jan; 28(1):15-25. PubMed ID: 26512030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care costs associated with gestational diabetes mellitus among high-risk women--results from a randomised trial.
    Kolu P; Raitanen J; Rissanen P; Luoto R
    BMC Pregnancy Childbirth; 2012 Jul; 12():71. PubMed ID: 22827919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-effectiveness comparison of the NICE 2015 and WHO 2013 diagnostic criteria for women with gestational diabetes with and without risk factors.
    Jacklin PB; Maresh MJ; Patterson CC; Stanley KP; Dornhorst A; Burman-Roy S; Bilous RW
    BMJ Open; 2017 Aug; 7(8):e016621. PubMed ID: 28801424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland.
    Gillespie P; O'Neill C; Adams E; Turner K; O'Donovan D; Brugha R; Vaughan D; O'Connell E; Cormican M; Balfe M; Coleman C; Fitzgerald M; Fleming C
    Sex Transm Infect; 2012 Apr; 88(3):222-8. PubMed ID: 22213681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for gestational diabetes mellitus in primary versus secondary care: The clinical outcomes of a randomised controlled trial.
    O'Dea A; Tierney M; Danyliv A; Glynn LG; McGuire BE; Carmody LA; Newell J; Dunne FP
    Diabetes Res Clin Pract; 2016 Jul; 117():55-63. PubMed ID: 27329023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the cost-effectiveness of alcohol screening and brief interventions in primary care in England.
    Purshouse RC; Brennan A; Rafia R; Latimer NR; Archer RJ; Angus CR; Preston LR; Meier PS
    Alcohol Alcohol; 2013; 48(2):180-8. PubMed ID: 23015608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term cost effectiveness of cardiac secondary prevention in primary care in the Republic of Ireland and Northern Ireland.
    Gillespie P; Murphy E; Smith SM; Cupples ME; Byrne M; Murphy AW
    Eur J Health Econ; 2017 Apr; 18(3):321-335. PubMed ID: 26961365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of an exercise program during pregnancy to prevent gestational diabetes: results of an economic evaluation alongside a randomised controlled trial.
    Oostdam N; Bosmans J; Wouters MG; Eekhoff EM; van Mechelen W; van Poppel MN
    BMC Pregnancy Childbirth; 2012 Jul; 12():64. PubMed ID: 22762376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of controlling gestational diabetes mellitus: a systematic review.
    Fitria N; van Asselt ADI; Postma MJ
    Eur J Health Econ; 2019 Apr; 20(3):407-417. PubMed ID: 30229375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.